Sun Pharma shares in focus after Q3 profit beats estimates; Nuvama raises target price
Sun Pharma reported a 15% YoY rise in Q3FY25 profit to Rs 2,903 crore, surpassing estimates. Revenue grew 10% to Rs 13,675.5 ...